The Registry of Toxic Effects of Chemical Substances
Ethylene, chloro - |
UPDATE: May 2005 | MW: 62.50 | MF: C2H3Cl |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
inhalation | hamster
12,500 ppm/6 hour
|
ARTODN 45,1,1980
|
cytogenetic analysis
|
multiple | hamster
600 mg/kg
|
MUREAV 53,187,1978
|
cytogenetic analysis
|
human
HeLa cell
|
10 mmol/L
|
TXCYAC 9,21,1978
|
cytogenetic analysis
|
inhalation | rat
150 µg/m3/14 week- continuous
|
GISAAA 43(7),111,1978
|
DNA adduct
|
oral | rat
18 gm/kg/2 year- continuous
|
CBINA8 22,211,1978
|
DNA damage
|
inhalation | rat
205 ppm/5 hour
|
CBINA8 37,219,1981
|
DNA inhibition
|
intravenous | rat
9,500 µg/kg
|
CBINA8 17,239,1977
|
DNA repair
|
Escherichia coli
|
100 µg/plate
|
MUREAV 54,101,1978
|
unscheduled DNA synthesis
|
rat
liver
|
2,100 µmol/L
|
CRNGDP 5,1629,1984
|
host-mediated assay
|
mouse
| Schizosaccharomyces pombe
700 mg/kg
|
MUREAV 40,85,1976
|
host-mediated assay
|
mouse
| Saccharomyes cerevisiae
700 mg/kg
|
TOERD9 3,131,1981
|
host-mediated assay
|
rat
| Saccharomyes cerevisiae
1 pph/24 hour- continuous
|
MUREAV 91,381,1981
|
mutation in microorganisms
|
Escherichia coli
|
10,600 µmol/L (+enzymatic activation step)
|
BCPCA6 24,2013,1975
|
mutation in microorganisms
|
hamster
lung
|
20 pph/5 hour (+enzymatic activation step)
|
MUREAV 67,173,1979
|
mutation in microorganisms
|
Salmonella typhimurium
|
2,000 ppm/48 hour (+enzymatic activation step)
|
BBRCA9 63,363,1975
|
mutation in microorganisms
|
Salmonella typhimurium
|
1 pph (-enzymatic activation step)
|
CBTOE2 1(3),159,1985
|
mutation in microorganisms
|
Schizosaccharomyces pombe
|
16 mmol/L/30 minute (+enzymatic activation step)
|
MUREAV 40,85,1976
|
micronucleus test
|
hamster
embryo
|
30 pph
|
MUREAV 203,397,1988
|
micronucleus test
|
inhalation | mouse
5 pph/4 hour
|
MUREAV 75,191,1980
|
gene conversion and mitotic recombination
|
Saccharomyes cerevisiae
|
48 mmol/L/3 hour
|
MUREAV 40,85,1976
|
mutation in mammalian somatic cells
|
hamster
ovary
|
10 pph
|
EVSRBT 25,91,1982
|
mutation in mammalian somatic cells
|
human
lymphocyte
|
7,500 ppt
|
CRNGDP 18,31,1997
|
morphological transform
|
mouse
embryo
|
75 mg/L
|
CALEDQ 28,85,1985
|
morphological transform
|
inhalation | rat
2,000 ppm/14 week- intermittent
|
ARTODN 47,71,1981
|
sister chromatid exchange
|
inhalation | hamster
12,500 ppm/6 hour
|
ARTODN 45,1,1980
|
sex chromosome loss and nondisjunction
|
inhalation | Drosophila melanogaster
1 pph
|
MUREAV 57,307,1978
|
specific locus test
|
inhalation | Drosophila melanogaster
48,500 ppm
|
CRNGDP 17,1083,1996
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | man
lowest published toxic concentration: 30 mg/m3 (5 year male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
GTPZAB 24(5),28,1980
|
inhalation | mouse
lowest published toxic concentration: 30,000 ppm/6 hour (5 day male)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea)
|
EVHPAZ 21,71,1977
|
inhalation | mouse
lowest published toxic concentration: 500 ppm/7 hour (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
EVHPAZ 41,171,1981
|
inhalation | rat
lowest published toxic concentration: 100 ppm/6 hour (26 week male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
EESADV 10,281,1985
|
inhalation | rat
lowest published toxic concentration: 500 ppm/7 hour (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TXAPA9 33,134,1975
|
inhalation | rat
lowest published toxic concentration: 1,500 ppm/24 hour (1-9 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
TXCYAC 11,45,1978
|
inhalation | rat
lowest published toxic concentration: 500 ppm/7 hour (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
EVHPAZ 41,171,1981
|
inhalation | rat
lowest published toxic concentration: 250 ppm/6 hour (55 day prior to copulation)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated)
|
JTEHD6 3,965,1977
|
inhalation | rabbit
lowest published toxic concentration: 500 ppm/7 hour (6-18 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
EVHPAZ 41,171,1981
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | hamster
lowest published toxic concentration: 50 ppm/4 hour/30 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Blood: Lymphoma including Hodgkin's disease Skin and Appendages: Tumors
APDCDT 3,216,1976
|
inhalation | human
toxic concentration (other than lowest) : 300 mg/m3/1 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Blood: Tumors
GTPZAB 26(1),28,1982
|
inhalation | man
lowest published toxic concentration: 200 ppm/14 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
VAPHDQ 372,195,1976
|
inhalation | mouse
lowest published toxic concentration: 50 ppm/30 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Vascular: Tumors Skin and Appendages: Tumors
ANYAA9 271,431,1976
|
inhalation | mouse
toxic concentration (other than lowest) : 50 ppm/47 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Liver: Tumors
JTEHD6 4,15,1978
|
inhalation | mouse
toxic concentration (other than lowest) : 50 ppm/6 hour/4 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors
JTEHD6 7,909,1981
|
inhalation | mouse
toxic concentration (other than lowest) : 50 ppm/4 hour/30 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Skin and Appendages: Tumors
CSHCAL 4,119,1977
|
inhalation | rat
lowest published toxic concentration: 1 ppm/4 hour/52 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Skin and Appendages: Tumors
EVHPAZ 41,3,1981
|
inhalation | rat
lowest published toxic concentration: 10,000 ppm/4 hour (12-18 day pregnant)
|
Tumorigenic: Carcinogenic by RTECS criteria | Reproductive: Tumorigenic effects: Transplacental tumorigenesis Endocrine: Tumors
CSHCAL 4,119,1977
|
inhalation | rat
toxic concentration (other than lowest) : 50 ppm/7 hour/26 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Vascular: Tumors Skin and Appendages: Tumors
TXAPA9 68,120,1983
|
inhalation | rat
toxic concentration (other than lowest) : 100 ppm/7 hour/26 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Skin and Appendages: Tumors
TXAPA9 68,120,1983
|
inhalation | rat
toxic concentration (other than lowest) : 250 ppm/2 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Ear: Tumors Liver: Angiosarcoma
AANLAW 56,1,1974
|
inhalation | rat
toxic concentration (other than lowest) : 5 ppm/4 hour/52 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Skin and Appendages: Tumors
EVHPAZ 41,3,1981
|
inhalation | rat
toxic concentration (other than lowest) : 50 ppm/6 hour/43 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Skin and Appendages: Tumors
JTEHD6 7,909,1981
|
inhalation | rat
lowest published toxic concentration: 128 mg/m3/1 year- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Angiosarcoma
VCVGH* -,422,1990
|
inhalation | rat
lowest published toxic concentration: 77,000 mg/m3/6 minute
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Musculoskeletal: Tumors Lung, Thorax, or Respiration: Tumors
VCVGH* -,422,1990
|
intraperitoneal | rat
lowest published toxic dose: 21 mg/kg/65 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Skin and Appendages: Tumors Gastrointestinal: Tumors
APDCDT 3,216,1976
|
oral | rat
lowest published toxic dose: 3,463 mg/kg/52 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Kidney, Ureter, and Bladder: Kidney tumors
EVHPAZ 41,3,1981
|
oral | rat
toxic dose : 34 gm/kg/3 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Angiosarcoma Kidney, Ureter, and Bladder: Kidney tumors
EVHPAZ 21,1,1977
|
subcutaneous | rat
lowest published toxic dose: 21 mg/kg/67 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Skin and Appendages: Tumors
APDCDT 3,216,1976
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | dog
lowest published toxic concentration: 517,000 mg/m3/1 hour
|
Behavioral: General anesthetic
|
VCVGH* -,420,1990
|
inhalation | dog
lowest published lethal concentration: 1,034,000 mg/m3/4 hour
|
N/R
|
VCVGH* -,420,1990
|
inhalation | dog
lethal concentration (50 percent kill): 260,000 mg/m3
|
N/R
|
VCVGH* -,420,1990
|
inhalation | guinea pig
lowest published lethal concentration: 30 pph/30 minute
|
Behavioral: General anesthetic
|
AIHAAP 21,394,1960
|
inhalation | guinea pig
lowest published toxic concentration: 258,000 mg/m3/90 minute
|
Behavioral: General anesthetic
|
VCVGH* -,420,1990
|
inhalation | guinea pig
lowest published lethal concentration: 1,552,000 mg/m3/18 minute
|
N/R
|
VCVGH* -,420,1990
|
inhalation | human
lowest published toxic concentration: 1,320 mg/m3/7 hour
|
Behavioral: Headache
|
VCVGH* -,421,1990
|
inhalation | human
lowest published toxic concentration: 16,000 mg/m3/5 minute
|
Ear: Change in acuity | Behavioral: Headache Gastrointestinal: Nausea or vomiting
VCVGH* -,421,1990
|
inhalation | mammal (species unspecified)
lowest published lethal concentration: 200 ppm/18 minute
|
N/R
|
IPSTB3 3,93,1976
|
inhalation | mouse
lowest published lethal concentration: 20 pph/30 minute
|
Behavioral: General anesthetic
|
AIHAAP 21,394,1960
|
inhalation | mouse
lowest published lethal concentration: 1,056,000 mg/m3/15 minute
|
N/R
|
VCVGH* -,420,1990
|
inhalation | mouse
lowest published lethal concentration: 185,000 mg/m3/1 hour
|
N/R
|
VCVGH* -,420,1990
|
inhalation | rat
lethal concentration (50 percent kill): 18 pph/15 minute
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Respiratory depression
HUTODJ 1,239,1982
|
oral | rat
lethal dose (50 percent kill): 500 mg/kg
|
N/R
|
DOWCC*
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 30 mg/m3/4 hour/26 week- intermittent
|
Cardiac: Arrythmias (indlucing changes in conduction) | Cardiac: EKG changes not diagnostic of above Cardiac: Pulse rate decreased with fall in BP
GTPZAB 16(2),24,1972
|
inhalation | rat
lowest published toxic concentration: 5,000 ppm/7 hour/52 week- intermittent
|
Liver: Changes in liver weight | Kidney, Ureter, and Bladder: Changes in bladder weight Endocrine: Changes in spleen weight
TXCYAC 13,25,1979
|
inhalation | rat
lowest published toxic concentration: 400 mg/m3/24 hour/14 week- continuous
|
Behavioral: Muscle contraction or spasticity | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Liver: Changes in liver weight
GISAAA 44(11),74,1979
|
inhalation | rat
lowest published toxic concentration: 28,000 ppm/7 hour/6 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
TXAPA9 62,1,1982
|
inhalation | rat
lowest published toxic concentration: 2,000 ppm/8 hour/92 day- intermittent
|
Liver: Changes in liver weight | Endocrine: Changes in spleen weight Blood: Changes in leukocyte (WBC) count
AIHAAP 24,265,1963
|
inhalation | rat
lowest published toxic concentration: 30 mg/m3/4 hour/20 day- intermittent
|
Cardiac: EKG changes not diagnostic of above
|
VCVGH* -,422,1990
|
inhalation | rat
lowest published toxic concentration: 30 mg/m3/4 hour/18 week- intermittent
|
Cardiac: Arrythmias (indlucing changes in conduction)
|
VCVGH* -,422,1990
|
inhalation | rat
lowest published toxic concentration: 300 mg/m3/4 hour/28 week- intermittent
|
Autonomic Nervous System: Other (direct) parasympathomimetic
|
VCVGH* -,422,1990
|
inhalation | rabbit
lowest published toxic concentration: 9 gm/m3/4 hour/22 week- intermittent
|
Cardiac: Arrythmias (indlucing changes in conduction) | Cardiac: EKG changes not diagnostic of above Cardiac: Pulse rate decreased with fall in BP
GTPZAB 12(7),47,1968
|
inhalation | rabbit
lowest published toxic concentration: 30 mg/m3/26 week- intermittent
|
Brain and Coverings: Recordings from specific areas of CNS | Blood: Other changes Musculoskeletal: Osteoporosis
GTPZAB 16(2),24,1972
|
inhalation | rabbit
lowest published toxic concentration: 30 mg/m3/4 hour/4 week- intermittent
|
Cardiac: Arrythmias (indlucing changes in conduction) | Musculoskeletal: Other changes
VCVGH* -,422,1990
|
inhalation | rabbit
lowest published toxic concentration: 900 mg/m3/8 week- continuous
|
Cardiac: EKG changes not diagnostic of above | Vascular: BP elevation not characterized in autonomic section Vascular: Measurement of regional blood flow
VCVGH* -,422,1990
|
oral | rat
lowest published toxic dose: 23,400 mg/kg/13 week- intermittent
|
Liver: Changes in liver weight | Blood: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
FCTXAV 13,633,1975
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 1 ppm
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Confirmed Human Carcinogen
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Sufficient Evidence
|
IMEMDT 19,377,1979
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 19,377,1979
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 1
|
IMSUDL 7,373,1987
|
TOXICOLOGY REVIEW
|
|
MUREAV 566,21,2004
|
TOXICOLOGY REVIEW
|
|
JTEHD6 1,47,1975
|
TOXICOLOGY REVIEW
|
|
CMTVAS 10(3),49,1973
|
TOXICOLOGY REVIEW
|
|
CHWEAP 70(28/29),5,1974
|
TOXICOLOGY REVIEW
|
|
CANCAR 39,1792,1977
|
TOXICOLOGY REVIEW
|
|
MUREAV 32,93,1975
|
TOXICOLOGY REVIEW
|
|
ZHPMAT 166,113,1978
|
TOXICOLOGY REVIEW
|
|
BNYMAM 54,413,1978
|
TOXICOLOGY REVIEW
|
|
ABMHAM 35,585,1977
|
TOXICOLOGY REVIEW
|
|
CBINA8 22,117,1978
|
TOXICOLOGY REVIEW
|
|
GTPZAB 20(4),46,1976
|
TOXICOLOGY REVIEW
|
|
VHTODE 22,31,1980
|
TOXICOLOGY REVIEW
|
|
MUREAV 41,131,1976
|
TOXICOLOGY REVIEW
|
|
TOLED5 138,9,2003
|
TOXICOLOGY REVIEW
|
|
MUREAV 5432012003
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,109,2004
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 200 ppm (510 mg/m3)
|
DTLWS* 3,31,1973
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
see Code of Federal Regulations (CFR) 29,1926.1117
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 500 ppm (13 mg/m3)
|
CFRGBR 41,50-204.50,1994
|
Occupational Safety and Health Administration (OSHA)
|
cancer suspect agent
|
CFRGBR 29,1910.1017,1987
|
Occupational Exposure Limit - ARAB Republic of Egypt
|
time-weighted average 2.5 mg/m3, JAN1993
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 5 ppm (10 mg/m3), Carcinogen, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 5 ppm (13 mg/m3), Carcinogen JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 1 ppm (3 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 5 ppm (15 mg/m3), short term exposure limit 10 ppm (30 mg/m3), Carcinogen, JAN1993
|
Occupational Exposure Limit - GERMANY
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - HUNGARY
|
short term exposure limit 10 mg/m3, Carcinogen, JAN1993
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit( continuous) 2.5 ppm (6.5 mg/m3), Group intermittent Carcinogen, JAN1999
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 7.77 mg/m3, 2003
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 1 ppm (3 mg/m3), JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 50 ppm (100 mg/m3), JAN1993
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 5 mg/m3, MAC(short term exposure limit) 30 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
time-weighted average 1 mg/m3, short term exposure limit 2.5 ppm (5 mg/m3), JAN1993
|
Occupational Exposure Limit - SWEDEN
|
NGV 1 ppm (2.5 mg/m3), KTV 5 ppm (13 mg/m3), Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 2 ppm (5.2 mg/m3), Carcinogen, JAN1999
|
Occupational Exposure Limit - THAILAND
|
time-weighted average 1 ppm (2.8 mg/m3), JAN1993
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 500 ppm (1300 mg/m3), JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 7 ppm, Carcubigen, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Confirmed Human Carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Confirmed Human Carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO VINYL CHLORIDE-air
|
Carcinogen lowest feasible concentration
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 76445; | Number of Industries 22; Total Number of Facilities 1,459; Number of Occupations 36; Total Number of Employees Exposed 29,836
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 76445; |
Number of Industries 63; Total Number of Facilities 3,711; Number of Occupations 59; Total Number of Employees Exposed 81,314; Total Number of Female Employees Exposed 28,398 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101132/AS)
|
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat
|
EPA GENETOX PROGRAM 1988, Positive: In vivo cytogenetics-human lymphocyte; E coli polA with S9
|
EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test
|
EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal
|
EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; S pombe-forward mutation
|
EPA GENETOX PROGRAM 1988, Negative: D melanogaster-reciprocal translocation
|
EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal; Mouse spot test
|
EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used in the production of VINYL CHLORIDE homopolymer and copolymer resins
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN 28, 1978
|
NIOSH Analytical Method, 1994: Vinyl chloride, 1007
|
NTP 11th Report on Carcinogens,2004:Known to be human carcinogen
|
OSHA ANALYTICAL METHOD #04
|
|
REFERENCES:
CODEN
|
|
REFERENCE
AANLAW
|
Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali,
Rendiconti. (Academia Nazionale dei Lincei, Via della Lungara, 10, I-00165 Rome, Italy)
1892-1939; Ser. 8: V.1- 1946-
|
ABMHAM
|
Archives Belges de Medecine Sociale, Hygiene, Medecine du Trevail et Medecine Legale.
(Quartier Esplanade no.6, 1010 Brussels, Belgium) V.4- 1946-
|
AIHAAP
|
American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH
44311) V.19- 1958-
|
ANYAA9
|
Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New
York, NY 10021) V.1- 1877-
|
APDCDT
|
Advances in Tumour Prevention, Detection and Characterization. (New York, NY) V.1-5,
1974-80. Discontinued.
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
BBRCA9
|
Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St.,
Duluth, MN 55802) V.1- 1959-
|
BCPCA6
|
Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1958-
|
BNYMAM
|
Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St.,
New York, NY 10029) Ser 2: V.1- 1925-
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CANCAR
|
Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave.,
Hagerstown, MD 21740) V.1- 1948-
|
CBINA8
|
Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1969-
|
CBTOE2
|
Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279,
Princeton, NJ 08540) V.1- 1984-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CHWEAP
|
Chemisch-Weekblad. (The Hague, Netherlands) V.1-71, 1903-75.
|
CMTVAS
|
Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail,
rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
CSHCAL
|
Cold Spring Harbor Conferences on Cell Proliferation. (Cold Spring Harbor, NY) V.1-10,
1974-83.
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
DTLWS*
|
"Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For
publisher information, see 85INA8.
|
EESADV
|
Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1977-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
EVSRBT
|
Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1-
1972-
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
GTPZAB
|
Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see
MTPEEI
|
HUTODJ
|
Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1-
1981-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
IMSUDL
|
IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY
12210) No.1- 1979-
|
IPSTB3
|
International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury,
Shropshire SY4 4NR, UK)
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
TOERD9
|
Toxicological European Research. (S.P.E., 10, Ave. de Messine, 75008 Paris, France) V.1-
1978-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
VAPHDQ
|
Virchows Archiv A: Pathological Anatomy and Histology. (Berlin, Fed. Rep. Ger.) V.362-397,
1974-82.
|
VCVGH*
|
"Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances:
Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990.
|
VHTODE
|
Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology,
Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977-
|
ZHPMAT
|
Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung
1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin.
(Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC.
|
|